The approved products and active Phase 2 and Phase 3 obesity and metabolic candidates we follow, spanning the GLP-1, GIP, glucagon, amylin and related pathways with what each one targets, how far along it is, and what's genuinely coming next
Heliyon 9 , e20163 (2023)
How much weight comes back
(2025) National Library of Medicine
Questions to Ask Your Doctor If youre using a GLP-1 medication, its worth having a conversation about how to optimize your results
It may also facilitate broader insurance coverage so more patients with this common, but hard-to-detect cancer will have an opportunity to receive a comprehensive diagnosis that accelerates clinical decisions and early intervention. Cerianna is a molecular imaging agent indicated for use with PET imaging for the detection of ER+ lesions as an adjunct to biopsy in patients with known or suspected recurrent or metastatic breast cancer